This case study aims to emphasize the value of Fractional exhaled Nitric Oxide (FeNO) testing in asthma care and explain why the NObreath ® FeNO device is the product of choice. The NObreath ® ...

The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange ...

Researchers at the La Jolla Institute for Immunology (LJI) have developed a specific drug "cocktail" that promises to curb severe asthma flare-ups, potentially decreasing the reliance on inhalers ...